Share

POST-DURV "Observational study on treatment strategies in clinical practice in patients with stage III NSCLC progressing to consolidation therapy with Durvalumab"

Project objectives

This is a retrospective-prospective multicenter observational study of patients with NSCLC progressing on consolidation therapy with durvalumab.
The retrospective-prospective study design involves both a primary collection of data during the enrollment visit and the follow-up visit, and a secondary collection of data during the retrospective observation period. The primary objective of the study is the description of therapeutic strategies in patients who present clinical-radiological progression to consolidation therapy with durvalumab.

Start and end date

November 23, 2020 - In progress

Project Manager

Sara Ramella - Principal Investigator

Coordinating institution of the project

Pulmonary Oncology-Department of Oncology-University of Turin, AOU San Luigi, Orbassano

Other Institutions involved

  • AOU Parma (Dr.Alessandro Leonetti)
  • AOU Careggi-Florence (Dr. Vieri Scotti)
  • National Cancer Institute IRCCS Pascale Napoli (Dr. Alessandro Morabito)
  • San Camillo Hospital-Rome (Dr. Maria Rita Migliorino)
  • Regina Elena National Institute (Dr. Fabiana Cecere-Oncology A)
  • Milan Polyclinic (Dr. Francesco Grossi)
  • AO San Gerardo Monza (Dr. Diego Cortinovis)
  • Humanitas Gavezzeni-Bergamo (Dr. Giovanni Luca Ceresoli)
  • Ospedali Riuniti Padova Sud- Monselice (Dr. Rita Chiari)
  • AOU Integrated Verona (Dr. Sara Pilotto)
  • Veneto-Padova Oncology Institute (Dr. Giulia Pasello)
  •  Oncology Reference Center - Aviano (Dr. Alessandra Bearz)
  • Vito Fazzi Hospital (Dr. Gianpiero Romano)
  • SG Moscati Hospital - Taranto (Dr. Salvatore Pisconti)
  • IRCCS Tumor Institute-Bari (Dr. Domenico Galetta)
  •  Santo Spirito Hospital - Casale Monferrato (Dr Roberta Good)
  • AOU Maggiore della Carità-Novara (Dr. Gloria Borra)
  • City of Health and Science-Turin (Dr. Mario Airoldi)
  • Humanitas Gradenigo-Turin (Dr. Lucio Buffoni)
  • SanTA Maria della MIsericoria Hospital Perugia (Dr. Giulio Metro)
  •  San Martino Hospital – Genoa (Dr. Carlo Genova)
  • University Polyclinic Campus Biomedico-Rome (Prof Sara Ramella)
  •  L'Aquila Hospital (Dr. Corrado Ficorella)
  • AO Papardo-Messina (Doctor Tindara Franchina)
  • AOU Policlinico Vittorio Emanuele-Catania (Dr. Hector Soto Parra)
  •  Oncology ASL Frosinone (Dr. Olga Martelli)
  • Santa Croce and Carle Cuneo Hospital (Dr. Ida Colantonio)
  • Friuli Centrale Integrated University Health Company (Dr. Gianpiero Fasola)
  • Policlinico Umberto I Rome (Dr. Alain Gelibter)
  •  P. Pederzoli Hospital-Peschiera del Garda (Dr. Elisa Roca)
  • Cardinal Massaia Hospital Asti (Dr. Marcello Tucci)
  • ASSL Sassari (Dr. Carlo Putzu)
  • Sondalo Hospital Company (Dr. Giuseppe Valmadre)
  • Gemelli Polyclinic Rome (Prof. Emilio Bria)
  •  Regina Elena National Institute (Dr. Federio Cappuzzo-Oncology 2)
  • ASSL Olbia-Oncology (Dr. Claudio Sini)
  • IRCCS Sacred Heart Don Calabria-Verona (Dr. Stefania Gori)
  • IRCCS - Arcispedale S.Maria Nuova-Reggio Emilia (Dr. Carmine Pinto)
  • San Raffaele Hospital Milan (Dr. Vanesa Gregorc)
  • AO Ospedale dei Colli, Monaldi Hospital Naples (Dr. Danilo Rocco)
  • IRST Meldola (Dr. Angelo Delmonte)
  • ASST Pope Giovanni- XXIII Bergamo (Dr. Anna Cecilia Bettini)
magnifiercrossmenuchevron-downchevron-leftchevron-right